PEPTIDEREPORT

RUO supplier

Valar Peptides

Official public batch documents reviewed

Unclaimed profileReviewed Jul 12, 2026

Documentation access pick: Selected for unusually broad public access to supplier-issued product and batch documents. This label does not mean independent laboratory verification.

Visit official siteClaim this profile

Deep research review

Company status and documentation

Valar Peptides publishes an RUO catalog and links Valar-branded batch documents from most product pages. The sampled documents list lot-level purity and quantity results, but they do not name the laboratory that produced those results. Public certificates or original third-party reports supporting the site's U.S. manufacturing, third-party testing, GMP, and ISO claims were not found during this review.

What this review did not check: Private contracts, nonpublic facility records, independent batch testing, product safety, or product efficacy.

Documentation access audit

30 of 36 product pages linked to a public batch document

30product pages with a working document link
0sampled documents that named an independent lab
Jul 12, 2026last checked

All 30 working links opened Valar-branded batch documents. The two documents sampled in detail listed test results but did not identify the laboratory that produced them.

Findings

What the public record shows

Legal identity not confirmed

The reviewed pages did not disclose an operating legal entity or U.S. facility address, and the terms select United Arab Emirates law and courts.

Limit: The review did not include private contracts or nonpublic corporate records.

Observed Jul 12, 2026

valar-peptides: terms and conditions

Public Catalog

The public catalog lists individual peptides, blends, capsules, and cosmetic-category materials.

Limit: Catalog contents and availability can change.

Observed Jul 12, 2026

Valar Peptides: product catalog

Public sample report

A Semaglutide 10 mg document for lot SM10-01-825-v265 reports 99.89% HPLC purity, 10.71 mg net quantity, and an endotoxin result of conforms.

Limit: The document is Valar-branded, names an internal quality-control authorizer, and does not identify an independent laboratory. Results apply only to the listed lot.

Observed Jul 12, 2026

Valar Peptides: public report PDF

Public sample report

A GHK-Cu 50 mg document for lot GK50-01-905-g387 reports 99.88% HPLC purity, 52.27 mg net quantity, and blue to off-blue appearance.

Limit: The document does not identify an independent laboratory. Results apply only to the listed lot.

Observed Jul 12, 2026

Valar Peptides: public report PDF

Search limits

Regulatory and community checks

Limited regulatory search

No exact-name FDA warning letter, recall, or enforcement page surfaced in the limited FDA-site search.

Limit: Search absence is not regulatory clearance and does not establish that no action exists.

Observed Jul 12, 2026

No substantive indexed discussion found

No substantive exact-name Reddit thread surfaced in the indexed search used for this review.

Limit: Search absence is not evidence of reputation or lack of discussion. Personal assurances are not independent verification.

Observed Jul 12, 2026

Open company questions

What is still unresolved

  • What legal entity owns and operates valarpeptides.com?
  • What facility performs synthesis, and what certification scope supports the GMP and ISO claims?
  • Which outside laboratory performs the claimed third-party verification?
  • Can original third-party reports and verification keys be made public?
  • Why do the terms select United Arab Emirates law if operations are represented as U.S.-based?

Supplier documentation profile

Supplier type
Direct RUO catalog
Documentation
Public product-level COAs found on 30 of 36 catalog pages checked
RUO language
The site states that all products are for research and development use only, not for human consumption, and that Valar Peptides is not a 503A/503B compounding or outsourcing facility.
Testing claims
Public product-page COAs reviewed include a batch or lot number, analysis date, HPLC identity and purity results, measured peptide quantity, endotoxin result, instrument listing, and QC authorization. The supplier separately claims mass-spectrometry confirmation and third-party verification.

Normalized batch records

Testing reports

Each row becomes a stacked record on smaller screens. Coverage means the field appears in the source record. It is not a Peptide Report pass or independent reproduction.

ProductBatchLaboratoryDateMethodsFields presentRecord
GHK-Cu 50 mg research materialGK50-01-905-g387Not named in supplier-issued documentNov 20, 2025HPLC, LALidentity, purity, net Content, endotoxinSource report
Ipamorelin 10 mg research materialIP10-01-817-u429Not named in supplier-issued documentAug 27, 2025HPLC, LALidentity, purity, net Content, endotoxinSource report
Semaglutide 10 mg research materialSM10-01-825-v265Not named in supplier-issued documentAug 25, 2025HPLC, LALidentity, purity, net Content, endotoxinSource report
TB-500 5 mg research materialTB05-01-827-c214Not named in supplier-issued documentAug 19, 2025HPLC, LALidentity, purity, net Content, endotoxinSource report
CJC-1295 no DAC 5 mg research materialCJ05-01-807-p482Not named in supplier-issued documentAug 19, 2025HPLC, LALidentity, purity, net Content, endotoxinSource report
Retatrutide 5 mg research materialRT05-01-625-b112Not named in supplier-issued documentJul 11, 2025HPLC, LALidentity, purity, net Content, endotoxinSource report

Observed catalog records

Products connected to evidence records

Editorial record

The requested valarresearch.com domain did not resolve and had no .com registry record when checked; the operating site found was valarpeptides.com. On July 10, 2026, 30 of the 36 products linked from its catalog had working public COA PDFs; AOD-9604, Hexarelin, NAD+, Oxytocin, Pinealon capsules, and Tirzepatide stated that no COA was available yet. The reviewed COAs name a Valar QC authorizer but not an independent laboratory, so they substantiate public batch documentation without independently verifying the site's third-party-testing claim. 'GMP comparable' is not evidence of GMP certification; the terms select UAE law while the site claims U.S. manufacturing.

Profile ownership: unclaimed. Company representatives will be able to propose identity and catalog updates without changing editorial or regulatory records.

Official sources

Official source 1Official source 2Official source 3Official source 4Official source 5